Three Antidepressants and No One Checked Your B12 or Hormones? Metabolic Disorders of the Brain

You get an antidepressant, and it doesn't work, so you get put on another one, and that one doesn't work either. Then somebody decides, since nothing's working, let's add an antipsychotic to boost the antidepressant. And all the while, you're walking around with extremely low B12 and vitamin D levels that nobody checked. If those had been corrected, maybe the antidepressants would have worked. Or maybe you never would have needed them.

That isn't one bad doctor. It's the system. In 2006, a trial called STAR*D walked about 4,000 people with depression down that same staircase. About 37% went into remission at the first step, 31% at the second, and about 14% and 13% at the third and fourth. The results paper doesn't report a single thyroid, B12, vitamin D or blood sugar level for anyone, at any step.

A whole field says this is backwards. It's called metabolic psychiatry, and the name I like for what it describes is metabolic disorders of the brain.

Your brain runs on fuel

Your brain is about 2% of your body weight and burns roughly 20% of your energy. The power plants that make that energy are the mitochondria inside your cells, and a 2017 paper on mitochondria and psychiatric illness explains why that matters: when energy production slips, the brain is the first organ to run short.

Insulin resistance and struggling mitochondria feed each other, and the first step in making cortisol, estradiol, testosterone and progesterone happens inside the mitochondria. That's why a hormone clinic and a psychiatry office keep running into each other. (More on insulin resistance.)

The metabolic trouble shows up first

  • A British study followed children from age 9 to 24. The ones whose fasting insulin ran persistently high had about five times the odds of being at high risk for psychosis by 24, and their average blood sugar was still normal (2021).

  • A Swedish study of more than 200,000 adults followed for 21 years on average: higher glucose and triglycerides predicted later depression, anxiety and stress related disorders, and they were running higher for 20 years before the diagnosis (2024).

  • In 121 adults with bipolar disorder, more than half had insulin resistance or type 2 diabetes, about a third had insulin resistance nobody knew about because their fasting glucose was normal, and the patients with insulin resistance or diabetes had about eight times the odds of not responding to lithium (2015).

The first two show order. None proves cause, and the order is the point. In my view, insulin resistance is a central root cause of chronic disease, and the brain isn't exempt.

What the prescribing books admit

A 2023 umbrella review found no consistent evidence of a link between serotonin and depression. The standard psychopharmacology textbook says there's no clear and convincing evidence that a monoamine deficiency accounts for depression, and its 2021 edition calls the idea that mental illnesses are simply chemical imbalances a "now dated notion." The FDA label for bupropion (Wellbutrin) says its mechanism of action is unknown, "as is the case with other antidepressants."

Off label prescribing is routine in psychiatry: in 2001, about one in three psychiatric prescriptions in US doctors' offices was off label, and more than nine in ten of those uses lacked strong scientific support (2006). Nobody calls that reckless. Prescribe a hormone off label, and suddenly it's dangerous. A psychiatric drug doesn't work? Bump the dose. A hormone didn't work at a low dose? You must not be a candidate for hormones. It's just very backwards.

The cascade has a price

A 2020 analysis of 100 trials found olanzapine and clozapine added close to 3 kilograms over placebo in about six weeks, and both raised blood sugar. Many antipsychotics also raise prolactin, which can shut down a woman's estradiol and drag a man's testosterone down. Keep the antipsychotic, but address the hormones.

Hormones are mood medicine

  • Thyroid. In STAR*D's third step, T3 did about as well as lithium, 25% remission against 16%, the highest rate of any treatment at that step, and fewer people quit it for side effects (about 10% against 23%). In my opinion, psychiatrists should be managing thyroid problems, not endocrinologists.

  • Estradiol. In a 2001 trial in perimenopausal women with depression, 68% on an estradiol patch went into remission, against 20% on placebo.

  • Progesterone. The liver turns part of it into allopregnanolone, which calms the brain. Two drugs were approved for postpartum depression: brexanolone, which is allopregnanolone given by IV, and a pill. I would never prescribe these drugs, because progesterone works far better.

  • Testosterone. A 2019 analysis found that, in randomized trials measuring response, men on testosterone had about 2.3 times the odds of a meaningful one. I do not think men are depressed because they are low in serotonin.

Your lab list: take this to your appointment

Symptoms dictate treatment. Labs matter most at baseline, to catch what needs catching, and a baseline that never gets drawn can't catch anything. A normal blood count doesn't rule out B12 deficiency: in 1988, more than a quarter of 141 patients with B12-driven psychiatric and nerve problems were missing the anemia, the enlarged red cells, or both. In a 2013 trial, B12 shots for low normal levels, added to an antidepressant, improved every treated person by at least a fifth.

My targets:

  • B12: above 1,000

  • Vitamin D: around 90 to 100

  • Ferritin: 75 or higher

  • Full thyroid panel, not just TSH, with free T3 of at least 4.0

  • Fasting insulin under 5, triglycerides under 50, HDL over 60, triglyceride to HDL ratio under 1.5

  • Women: estradiol at least 75, testosterone above 250

  • Men: testosterone at least above 1,000

If only a TSH was checked, that's where to start. (More on reference ranges.)

Food, movement, sleep and therapy are treatment

In a 2017 trial, 32% of people with depression who got help switching to a Mediterranean style diet went into remission, against 8% with social support. In four trials that put exercise head to head with sertraline, exercise did about as well (2013). In a 2024 Stanford pilot, a supervised ketogenic diet took metabolic syndrome from 29% of patients with bipolar disorder or schizophrenia to zero, with medications kept in place. One night of four hours' sleep makes healthy adults about a quarter less sensitive to insulin (2010).

And hormones, vitamins and antidepressants are never going to address trauma. Therapy really does matter, and most people have trauma.

Keep the medication. Fix the metabolism.

Never stop a psychiatric medication on your own. When adults on a long term stimulant were switched abruptly to placebo, three in four relapsed within six weeks (2012). Optimize first: thyroid, sex hormones, B12, vitamin D, sleep, insulin resistance. Then, if it makes sense, the prescriber brings the medication down slowly. Some people never come off, and that's okay.

If you're on your third antidepressant, you're not broken, and you're not out of options. Ask what was checked, and ask why not. If you're having thoughts of suicide, in the US you can call or text 988, any time.

The whole argument:

Listen to podcast Part One on Spotify

Listen to podcast Part Two on Spotify

⚠️ Educational content, not individual medical advice or a treatment recommendation. Nobody should start, stop or change a prescription because of an article. Your labs and history belong in a one on one.

🩺 DNP led telehealth hormone optimization. Book a consultation and find everything: withinyou.health/links

Sources

Agnew-Blais, J. C., et al. (2016). Evaluation of the Persistence, Remission, and Emergence of Attention-Deficit/Hyperactivity Disorder in Young Adulthood. JAMA Psychiatry, 73(7), 713-20. https://doi.org/10.1001/jamapsychiatry.2016.0465

Alberti, S., et al. (2015). Insomnia and somnolence associated with second-generation antidepressants during the treatment of major depression: a meta-analysis. J Clin Psychopharmacol, 35(3), 296-303. https://doi.org/10.1097/JCP.0000000000000329

Alevizaki, M., et al. (2005). TSH may not be a good marker for adequate thyroid hormone replacement therapy. Wien Klin Wochenschr, 117(18), 636-40. https://doi.org/10.1007/s00508-005-0421-0

Allcott, H., et al. (2019). The welfare effects of social media (NBER Working Paper No. 25514). National Bureau of Economic Research.

Anderson, K. N., et al. (2018). Attention-Deficit/Hyperactivity Disorder Medication Prescription Claims Among Privately Insured Women Aged 15-44 Years - United States, 2003-2015. MMWR Morb Mortal Wkly Rep, 67(2), 66-70. https://doi.org/10.15585/mmwr.mm6702a3

Aronson, R., et al. (1996). Triiodothyronine augmentation in the treatment of refractory depression. A meta-analysis. Arch Gen Psychiatry, 53(9), 842-8. https://doi.org/10.1001/archpsyc.1996.01830090090013

Bachhuber, M. A., et al. (2016). Increasing Benzodiazepine Prescriptions and Overdose Mortality in the United States, 1996-2013. Am J Public Health, 106(4), 686-8. https://doi.org/10.2105/AJPH.2016.303061

Bausch Health US, LLC. (2025). WELLBUTRIN XL (bupropion hydrochloride extended-release) tablets, for oral use: Full prescribing information [Revised 11/2025].

Bhuvaneswar, C. G., et al. (2009). Adverse endocrine and metabolic effects of psychotropic drugs: selective clinical review. CNS Drugs, 23(12), 1003-21. https://doi.org/10.2165/11530020-000000000-00000

Biessels, G. J., et al. (2020). Understanding multifactorial brain changes in type 2 diabetes: a biomarker perspective. Lancet Neurol, 19(8), 699-710. https://doi.org/10.1016/S1474-4422(20)30139-3

Braghieri, L., et al. (2022). Social media and mental health (Discussion Paper No. 320). Collaborative Research Center Transregio 190 (Rationality and Competition).

Brams, M., et al. (2012). Maintenance of efficacy of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: randomized withdrawal design. J Clin Psychiatry, 73(7), 977-83. https://doi.org/10.4088/JCP.11m07430

Bunevičius, R., et al. (1999). Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypothyroidism. N Engl J Med, 340(6), 424-429.

Calkin, C. V. (2019). Insulin resistance takes center stage: a new paradigm in the progression of bipolar disorder. Ann Med, 51(5-6), 281-293. https://doi.org/10.1080/07853890.2019.1659511

Calkin, C. V., et al. (2015). Insulin resistance and outcome in bipolar disorder. Br J Psychiatry, 206(1), 52-7. https://doi.org/10.1192/bjp.bp.114.152850

Casula, S., et al. (2023). Are We Restoring Thyroid Hormone Signaling in Levothyroxine-Treated Patients With Residual Symptoms of Hypothyroidism?. Endocr Pract, 29(7), 581-588. https://doi.org/10.1016/j.eprac.2023.04.003

Chouinard, V. A., et al. (2019). Impaired insulin signaling in unaffected siblings and patients with first-episode psychosis. Mol Psychiatry, 24(10), 1513-1522. https://doi.org/10.1038/s41380-018-0045-1

Chourpiliadis, C., et al. (2024). Metabolic Profile and Long-Term Risk of Depression, Anxiety, and Stress-Related Disorders. JAMA Netw Open, 7(4), e244525. https://doi.org/10.1001/jamanetworkopen.2024.4525

Cooney, G. M., et al. (2013). Exercise for depression. Cochrane Database Syst Rev, 2013(9), CD004366. https://doi.org/10.1002/14651858.CD004366.pub6

Cooper-Kazaz, R., et al. (2007). Combined treatment with sertraline and liothyronine in major depression: a randomized, double-blind, placebo-controlled trial. Arch Gen Psychiatry, 64(6), 679-88. https://doi.org/10.1001/archpsyc.64.6.679

Coppen, A., & Bailey, J. (2000). Enhancement of the antidepressant action of fluoxetine by folic acid: a randomised, placebo controlled trial. J Affect Disord, 60(2), 121-30. https://doi.org/10.1016/s0165-0327(00)00153-1

Corona, G., et al. (2009). Selective serotonin reuptake inhibitor-induced sexual dysfunction. J Sex Med, 6(5), 1259-69. https://doi.org/10.1111/j.1743-6109.2009.01248.x

Cortese, S., et al. (2016). Association Between ADHD and Obesity: A Systematic Review and Meta-Analysis. Am J Psychiatry, 173(1), 34-43. https://doi.org/10.1176/appi.ajp.2015.15020266

Cosgrove, L., & Krimsky, S. (2012). A comparison of DSM-IV and DSM-5 panel members' financial associations with industry: a pernicious problem persists. PLoS Med, 9(3), e1001190. https://doi.org/10.1371/journal.pmed.1001190

Danan, A., et al. (2022). The Ketogenic Diet for Refractory Mental Illness: A Retrospective Analysis of 31 Inpatients. Front Psychiatry, 13, 951376. https://doi.org/10.3389/fpsyt.2022.951376

De Hert, M., et al. (2009). Metabolic syndrome in people with schizophrenia: a review. World Psychiatry, 8(1), 15-22. https://doi.org/10.1002/j.2051-5545.2009.tb00199.x

Deibert, D. C., & DeFronzo, R. A. (1980). Epinephrine-induced insulin resistance in man. J Clin Invest, 65(3), 717-21. https://doi.org/10.1172/JCI109718

Dennis, C. L., et al. (2008). Oestrogens and progestins for preventing and treating postpartum depression. Cochrane Database Syst Rev, CD001690. https://doi.org/10.1002/14651858.CD001690

Dhieb, D., & Bastaki, K. (2026). Decoding psychotropic-induced metabolic disturbances: gut-brain axis, multi-omics, and nutrition-lifestyle integration. Front Nutr, 13, 1778794. https://doi.org/10.3389/fnut.2026.1778794

Dichtel, L. E., et al. (2020). Low-Dose Testosterone Augmentation for Antidepressant-Resistant Major Depressive Disorder in Women: An 8-Week Randomized Placebo-Controlled Study. Am J Psychiatry, 177(10), 965-973. https://doi.org/10.1176/appi.ajp.2020.19080844

Dickson, R. A., et al. (2000). Hormonal Side Effects in Women: Typical Versus Atypical Antipsychotic Treatment. J Clin Psychiatry, 61(Suppl 3), 10-15.

Diviccaro, S., et al. (2022). Allopregnanolone: An overview on its synthesis and effects. J Neuroendocrinol, 34(2), e12996. https://doi.org/10.1111/jne.12996

Donga, E., et al. (2010). A single night of partial sleep deprivation induces insulin resistance in multiple metabolic pathways in healthy subjects. J Clin Endocrinol Metab, 95(6), 2963-8. https://doi.org/10.1210/jc.2009-2430

Drobnis, E. Z., & Nangia, A. K. (2017). Psychotropics and Male Reproduction. Adv Exp Med Biol, 1034, 63-101. https://doi.org/10.1007/978-3-319-69535-8_8

Epperson, C. N., et al. (2015). New onset executive function difficulties at menopause: a possible role for lisdexamfetamine. Psychopharmacology (Berl), 232(16), 3091-100. https://doi.org/10.1007/s00213-015-3953-7

Espeland, M. A., et al. (2013). Long-term effects on cognitive function of postmenopausal hormone therapy prescribed to women aged 50 to 55 years. JAMA Intern Med, 173(15), 1429-36. https://doi.org/10.1001/jamainternmed.2013.7727

Espeland, M. A., et al. (2017). Long-term Effects on Cognitive Trajectories of Postmenopausal Hormone Therapy in Two Age Groups. J Gerontol A Biol Sci Med Sci, 72(6), 838-845. https://doi.org/10.1093/gerona/glw156

Fava, M., et al. (1997). Folate, vitamin B12, and homocysteine in major depressive disorder. Am J Psychiatry, 154(3), 426-8. https://doi.org/10.1176/ajp.154.3.426

Felitti, V. J., et al. (1998). Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults. The Adverse Childhood Experiences (ACE) Study. Am J Prev Med, 14(4), 245-58. https://doi.org/10.1016/s0749-3797(98)00017-8

Fusar-Poli, P., et al. (2012). Striatal dopamine transporter alterations in ADHD: pathophysiology or adaptation to psychostimulants? A meta-analysis. Am J Psychiatry, 169(3), 264-72. https://doi.org/10.1176/appi.ajp.2011.11060940

Garcia-Argibay, M., et al. (2023). The association between type 2 diabetes and attention- deficit/hyperactivity disorder: A systematic review, meta-analysis, and population-based sibling study. Neurosci Biobehav Rev, 147, 105076. https://doi.org/10.1016/j.neubiorev.2023.105076

Garlow, S. J., et al. (2012). The combination of triiodothyronine (T3) and sertraline is not superior to sertraline monotherapy in the treatment of major depressive disorder. J Psychiatr Res, 46(11), 1406-13. https://doi.org/10.1016/j.jpsychires.2012.08.009

Geracioti, T. D., Jr. (2006). Identifying hypothyroidism's psychiatric presentations: Is the thyroid causing your patient's symptoms? Current Psychiatry, 5(11), 98-117.

Glass, J., et al. (2005). Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. BMJ, 331(7526), 1169. https://doi.org/10.1136/bmj.38623.768588.47

Gleason, C. E., et al. (2015). Effects of Hormone Therapy on Cognition and Mood in Recently Postmenopausal Women: Findings from the Randomized, Controlled KEEPS-Cognitive and Affective Study. PLoS Med, 12(6), e1001833; discussion e1001833. https://doi.org/10.1371/journal.pmed.1001833

Glynne, S., et al. (2026). Transdermal oestradiol and testosterone therapy for menopausal depression and mood symptoms: retrospective cohort study. Br J Psychiatry, 228(5), 409-418. https://doi.org/10.1192/bjp.2025.101

Godfrey, P. S. A., et al. (1990). Enhancement of recovery from psychiatric illness by methylfolate. Lancet, 336, 392-395.

Gordon, J. L., et al. (2018). Efficacy of Transdermal Estradiol and Micronized Progesterone in the Prevention of Depressive Symptoms in the Menopause Transition: A Randomized Clinical Trial. JAMA Psychiatry, 75(2), 149-157. https://doi.org/10.1001/jamapsychiatry.2017.3998

Gottlieb, D. J., et al. (2005). Association of sleep time with diabetes mellitus and impaired glucose tolerance. Arch Intern Med, 165(8), 863-7. https://doi.org/10.1001/archinte.165.8.863

Gründer, G., et al. (1999). Neuroendocrine response to antipsychotics: effects of drug type and gender. Biol Psychiatry, 45(1), 89-97. https://doi.org/10.1016/s0006-3223(98)00125-5

Guina, J., et al. (2015). Benzodiazepines for PTSD: A Systematic Review and Meta-Analysis. J Psychiatr Pract, 21(4), 281-303. https://doi.org/10.1097/PRA.0000000000000091

Hughes, K., et al. (2017). The effect of multiple adverse childhood experiences on health: a systematic review and meta-analysis. Lancet Public Health, 2(8), e356-e366. https://doi.org/10.1016/S2468-2667(17)30118-4

Huhn, M., et al. (2019). Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis. Lancet, 394(10202), 939-951. https://doi.org/10.1016/S0140-6736(19)31135-3

Hunt, M. G., et al. (2018). No More FOMO: Limiting Social Media Decreases Loneliness and Depression. J Soc Clin Psychol, 37(10), 751-768.

Hvas, A. M., et al. (2004). No effect of vitamin B-12 treatment on cognitive function and depression: a randomized placebo controlled study. J Affect Disord, 81(3), 269-73. https://doi.org/10.1016/S0165-0327(03)00169-1

Jabbar, A., et al. (2008). Vitamin B12 deficiency common in primary hypothyroidism. J Pak Med Assoc, 58(5), 258-61.

Jacka, F. N., et al. (2017). A randomised controlled trial of dietary improvement for adults with major depression (the 'SMILES' trial). BMC Med, 15(1), 23. https://doi.org/10.1186/s12916-017-0791-y

Jansen, E. C., et al. (2023). Sleep duration and timing are prospectively linked with insulin resistance during late adolescence. Obesity (Silver Spring), 31(4), 912-922. https://doi.org/10.1002/oby.23680

Jensen, P. S., et al. (2007). 3-year follow-up of the NIMH MTA study. J Am Acad Child Adolesc Psychiatry, 46(8), 989-1002. https://doi.org/10.1097/CHI.0b013e3180686d48

Joffe, R. T., et al. (1993). A placebo-controlled comparison of lithium and triiodothyronine augmentation of tricyclic antidepressants in unipolar refractory depression. Arch Gen Psychiatry, 50(5), 387-93. https://doi.org/10.1001/archpsyc.1993.01820170065008

Joyce, P. R., et al. (1984). Methylphenidate increases heart rate, blood pressure and plasma epinephrine in normal subjects. Life Sci, 34(18), 1707-11. https://doi.org/10.1016/0024-3205(84)90568-x

Kaviani, M., et al. (2020). Effects of vitamin D supplementation on depression and some involved neurotransmitters. J Affect Disord, 269, 28-35. https://doi.org/10.1016/j.jad.2020.03.029

Keijzers, G. B., et al. (2002). Caffeine can decrease insulin sensitivity in humans. Diabetes Care, 25(2), 364-9. https://doi.org/10.2337/diacare.25.2.364

Kelly, T. (2014). A favorable risk-benefit analysis of high dose thyroid for treatment of bipolar disorders with regard to osteoporosis. J Affect Disord, 166, 353-8. https://doi.org/10.1016/j.jad.2014.04.022

Kelly, T. (2015). An examination of myth: a favorable cardiovascular risk-benefit analysis of high-dose thyroid for affective disorders. J Affect Disord, 177, 49-58. https://doi.org/10.1016/j.jad.2015.01.016

Kelly, T., & Lieberman, D. Z. (2009). The use of triiodothyronine as an augmentation agent in treatment-resistant bipolar II and bipolar disorder NOS. J Affect Disord, 116(3), 222-6. https://doi.org/10.1016/j.jad.2008.12.010

Kelly, T. F., & Lieberman, D. Z. (2009). Long term augmentation with T3 in refractory major depression. J Affect Disord, 115(1-2), 230-3. https://doi.org/10.1016/j.jad.2008.09.022

Kelly, Y., et al. (2018). Social Media Use and Adolescent Mental Health: Findings From the UK Millennium Cohort Study. EClinicalMedicine, 6, 59-68. https://doi.org/10.1016/j.eclinm.2018.12.005

Kidwell, K. M., et al. (2015). Stimulant Medications and Sleep for Youth With ADHD: A Meta-analysis. Pediatrics, 136(6), 1144-53. https://doi.org/10.1542/peds.2015-1708

Kim, Y., et al. (2019). Mitochondria, Metabolism, and Redox Mechanisms in Psychiatric Disorders. Antioxid Redox Signal, 31(4), 275-317. https://doi.org/10.1089/ars.2018.7606

Kleinridders, A., et al. (2015). Insulin resistance in brain alters dopamine turnover and causes behavioral disorders. Proc Natl Acad Sci U S A, 112(11), 3463-8. https://doi.org/10.1073/pnas.1500877112

Klosinski, L. P., et al. (2015). White Matter Lipids as a Ketogenic Fuel Supply in Aging Female Brain: Implications for Alzheimer's Disease. EBioMedicine, 2(12), 1888-904. https://doi.org/10.1016/j.ebiom.2015.11.002

Konopka, A. R., et al. (2019). Metformin inhibits mitochondrial adaptations to aerobic exercise training in older adults. Aging Cell, 18(1), e12880. https://doi.org/10.1111/acel.12880

Kornelius, E., et al. (2024). The risk of depression, anxiety, and suicidal behavior in patients with obesity on glucagon like peptide-1 receptor agonist therapy. Sci Rep, 14(1), 24433. https://doi.org/10.1038/s41598-024-75965-2

Kramer, C. K., et al. (2009). Treated hypothyroidism, cognitive function, and depressed mood in old age: the Rancho Bernardo Study. Eur J Endocrinol, 161(6), 917-21. https://doi.org/10.1530/EJE-09-0606

Kulkarni, J., et al. (2008). Estrogen in severe mental illness: a potential new treatment approach. Arch Gen Psychiatry, 65(8), 955-60. https://doi.org/10.1001/archpsyc.65.8.955

Landau, Z., & Pinhas-Hamiel, O. (2019). Attention Deficit/Hyperactivity, the Metabolic Syndrome, and Type 2 Diabetes. Curr Diab Rep, 19(8), 46. https://doi.org/10.1007/s11892-019-1174-x

Layton, T. J., et al. (2018). Attention Deficit-Hyperactivity Disorder and Month of School Enrollment. N Engl J Med, 379(22), 2122-2130. https://doi.org/10.1056/NEJMoa1806828

Lembke, A. (2021). Dopamine nation: Finding balance in the age of indulgence. Dutton.

Lindenbaum, J., et al. (1988). Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis. N Engl J Med, 318(26), 1720-8. https://doi.org/10.1056/NEJM198806303182604

Maier, H., et al. (2018). S100B, Homocysteine, Vitamin B12, Folic Acid, and Procalcitonin Serum Levels in Remitters to Electroconvulsive Therapy: A Pilot Study. Dis Markers, 2018, 2358451. https://doi.org/10.1155/2018/2358451

Marks, I. M., et al. (1993). Alprazolam and exposure alone and combined in panic disorder with agoraphobia. A controlled study in London and Toronto. Br J Psychiatry, 162, 776-87. https://doi.org/10.1192/bjp.162.6.776

Matthijssen, A. M., et al. (2019). Continued Benefits of Methylphenidate in ADHD After 2 Years in Clinical Practice: A Randomized Placebo-Controlled Discontinuation Study. Am J Psychiatry, 176(9), 754-762. https://doi.org/10.1176/appi.ajp.2019.18111296

Meltzer-Brody, S., et al. (2018). Brexanolone injection in post-partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials. Lancet, 392(10152), 1058-1070. https://doi.org/10.1016/S0140-6736(18)31551-4

Mertens, J., et al. (2015). Differential responses to lithium in hyperexcitable neurons from patients with bipolar disorder. Nature, 527(7576), 95-9. https://doi.org/10.1038/nature15526

Misra, M., et al. (2004). Effects of psychiatric disorders and psychotropic medications on prolactin and bone metabolism. J Clin Psychiatry, 65(12), 1607-18; quiz 1590, 1760-1. https://doi.org/10.4088/jcp.v65n1205

Moffitt, T. E., et al. (2015). Is Adult ADHD a Childhood-Onset Neurodevelopmental Disorder? Evidence From a Four-Decade Longitudinal Cohort Study. Am J Psychiatry, 172(10), 967-77. https://doi.org/10.1176/appi.ajp.2015.14101266

Molina, B. S. G., et al. (2009). The MTA at 8 years: prospective follow-up of children treated for combined-type ADHD in a multisite study. J Am Acad Child Adolesc Psychiatry, 48(5), 484-500. https://doi.org/10.1097/CHI.0b013e31819c23d0

Moncrieff, J., et al. (2023). The serotonin theory of depression: a systematic umbrella review of the evidence. Mol Psychiatry, 28(8), 3243-3256. https://doi.org/10.1038/s41380-022-01661-0

Morris, G., et al. (2017). A model of the mitochondrial basis of bipolar disorder. Neurosci Biobehav Rev, 74(Pt A), 1-20. https://doi.org/10.1016/j.neubiorev.2017.01.014

Morris, M. C., et al. (2012). Relations among posttraumatic stress disorder, comorbid major depression, and HPA function: a systematic review and meta-analysis. Clin Psychol Rev, 32(4), 301-15. https://doi.org/10.1016/j.cpr.2012.02.002

Morrow, R. L., et al. (2012). Influence of relative age on diagnosis and treatment of attention-deficit/hyperactivity disorder in children. CMAJ, 184(7), 755-62. https://doi.org/10.1503/cmaj.111619

Mosconi, L., et al. (2017). Sex differences in Alzheimer risk: Brain imaging of endocrine vs chronologic aging. Neurology, 89(13), 1382-1390. https://doi.org/10.1212/WNL.0000000000004425

Mozaffari-Khosravi, H., et al. (2013). The effect of 2 different single injections of high dose of vitamin D on improving the depression in depressed patients with vitamin D deficiency: a randomized clinical trial. J Clin Psychopharmacol, 33(3), 378-85. https://doi.org/10.1097/JCP.0b013e31828f619a

The MTA Cooperative Group. (1999). A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Arch Gen Psychiatry, 56(12), 1073-1086.

Nasca, C., et al. (2018). Acetyl-l-carnitine deficiency in patients with major depressive disorder. Proc Natl Acad Sci U S A, 115(34), 8627-8632. https://doi.org/10.1073/pnas.1801609115

Nedeltcheva, A. V., et al. (2009). Exposure to recurrent sleep restriction in the setting of high caloric intake and physical inactivity results in increased insulin resistance and reduced glucose tolerance. J Clin Endocrinol Metab, 94(9), 3242-50. https://doi.org/10.1210/jc.2009-0483

Nemeroff, C. B., et al. (2003). Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma. Proc Natl Acad Sci U S A, 100(24), 14293-6. https://doi.org/10.1073/pnas.2336126100

Newcomer, J. W. (2007). Metabolic Considerations in the Use of Antipsychotic Medications: A Review of Recent Evidence. J Clin Psychiatry, 68(Suppl 1), 20-27.

Nierenberg, A. A., et al. (2006). A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: a STAR*D report. Am J Psychiatry, 163(9), 1519-30; quiz 1665. https://doi.org/10.1176/ajp.2006.163.9.1519

Office of the Surgeon General. (2023). Social media and youth mental health: The U.S. Surgeon General's advisory. U.S. Department of Health and Human Services.

Okereke, O. I., et al. (2020). Effect of Long-term Vitamin D3 Supplementation vs Placebo on Risk of Depression or Clinically Relevant Depressive Symptoms and on Change in Mood Scores: A Randomized Clinical Trial. JAMA, 324(5), 471-480. https://doi.org/10.1001/jama.2020.10224

Orben, A., & Przybylski, A. K. (2019). The association between adolescent well-being and digital technology use. Nat Hum Behav, 3(2), 173-182. https://doi.org/10.1038/s41562-018-0506-1

Osterweil, D., et al. (1992). Cognitive function in non-demented older adults with hypothyroidism. J Am Geriatr Soc, 40(4), 325-35. https://doi.org/10.1111/j.1532-5415.1992.tb02130.x

Palmer, C. M. (2022). Brain energy: A revolutionary breakthrough in understanding mental health: And improving treatment for anxiety, depression, OCD, PTSD, and more. BenBella Books.

Palmer, C. M., et al. (2019). The ketogenic diet and remission of psychotic symptoms in schizophrenia: Two case studies. Schizophr Res, 208, 439-440. https://doi.org/10.1016/j.schres.2019.03.019

Panther, S. G., et al. (2017). Off-label Prescribing Trends for ADHD Medications in Very Young Children. J Pediatr Pharmacol Ther, 22(6), 423-429. https://doi.org/10.5863/1551-6776-22.6.423

Pelsser, L. M., et al. (2011). Effects of a restricted elimination diet on the behaviour of children with attention-deficit hyperactivity disorder (INCA study): a randomised controlled trial. Lancet, 377(9764), 494-503. https://doi.org/10.1016/S0140-6736(10)62227-1

Penninx, B. W. J. H., & Lange, S. M. M. (2018). Metabolic syndrome in psychiatric patients: overview, mechanisms, and implications. Dialogues Clin Neurosci, 20(1), 63-73. https://doi.org/10.31887/DCNS.2018.20.1/bpenninx

Perry, B. I., et al. (2021). Longitudinal Trends in Childhood Insulin Levels and Body Mass Index and Associations With Risks of Psychosis and Depression in Young Adults. JAMA Psychiatry, 78(4), 416-425. https://doi.org/10.1001/jamapsychiatry.2020.4180

Pillinger, T., et al. (2017). Impaired Glucose Homeostasis in First-Episode Schizophrenia: A Systematic Review and Meta-analysis. JAMA Psychiatry, 74(3), 261-269. https://doi.org/10.1001/jamapsychiatry.2016.3803

Pillinger, T., et al. (2020). Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: a systematic review and network meta-analysis. Lancet Psychiatry, 7(1), 64-77. https://doi.org/10.1016/S2215-0366(19)30416-X

Piper, B. J., et al. (2018). Trends in use of prescription stimulants in the United States and Territories, 2006 to 2016. PLoS One, 13(11), e0206100. https://doi.org/10.1371/journal.pone.0206100

Planck, T., et al. (2021). Liothyronine Use in Hypothyroidism and its Effects on Cancer and Mortality. Thyroid, 31(5), 732-739. https://doi.org/10.1089/thy.2020.0388

Pope, H. G., Jr., et al. (2003). Testosterone gel supplementation for men with refractory depression: a randomized, placebo-controlled trial. Am J Psychiatry, 160(1), 105-111.

Pope, H. G., Jr., et al. (2010). Parallel-group placebo-controlled trial of testosterone gel in men with major depressive disorder displaying an incomplete response to standard antidepressant treatment. J Clin Psychopharmacol, 30(2), 126-34. https://doi.org/10.1097/JCP.0b013e3181d207ca

Radley, D. C., et al. (2006). Off-label prescribing among office-based physicians. Arch Intern Med, 166(9), 1021-6. https://doi.org/10.1001/archinte.166.9.1021

Rasgon, N. L., et al. (2014). Prospective randomized trial to assess effects of continuing hormone therapy on cerebral function in postmenopausal women at risk for dementia. PLoS One, 9(3), e89095. https://doi.org/10.1371/journal.pone.0089095

Récalt, A. M., & Cohen, D. (2019). Withdrawal Confounding in Randomized Controlled Trials of Antipsychotic, Antidepressant, and Stimulant Drugs, 2000-2017. Psychother Psychosom, 88(2), 105-113. https://doi.org/10.1159/000496734

Riehm, K. E., et al. (2019). Associations Between Time Spent Using Social Media and Internalizing and Externalizing Problems Among US Youth. JAMA Psychiatry, 76(12), 1266-1273. https://doi.org/10.1001/jamapsychiatry.2019.2325

Rizza, R. A., et al. (1982). Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor detect of insulin action. J Clin Endocrinol Metab, 54(1), 131-8. https://doi.org/10.1210/jcem-54-1-131

Roberts, A. L., et al. (2015). Posttraumatic stress disorder and incidence of type 2 diabetes mellitus in a sample of women: a 22-year longitudinal study. JAMA Psychiatry, 72(3), 203-10. https://doi.org/10.1001/jamapsychiatry.2014.2632

Ross, D. C., et al. (2002). Treatment of ADHD when tolerance to methylphenidate develops. Psychiatr Serv, 53(1), 102. https://doi.org/10.1176/appi.ps.53.1.102

Rothbaum, B. O., et al. (2014). A randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan War veterans. Am J Psychiatry, 171(6), 640-8. https://doi.org/10.1176/appi.ajp.2014.13121625

Rush, A. J., et al. (2006). Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry, 163(11), 1905-17. https://doi.org/10.1176/ajp.2006.163.11.1905

Samuels, M. H., et al. (2007). Health status, mood, and cognition in experimentally induced subclinical hypothyroidism. J Clin Endocrinol Metab, 92(7), 2545-51. https://doi.org/10.1210/jc.2007-0011

Scherrer, J. F., et al. (2018). The Role of Obesity in the Association Between Posttraumatic Stress Disorder and Incident Diabetes. JAMA Psychiatry, 75(11), 1189-1198. https://doi.org/10.1001/jamapsychiatry.2018.2028

Scherrer, J. F., et al. (2019). Association Between Clinically Meaningful Posttraumatic Stress Disorder Improvement and Risk of Type 2 Diabetes. JAMA Psychiatry, 76(11), 1159-1166. https://doi.org/10.1001/jamapsychiatry.2019.2096

Schmidt, P. J., et al. (2000). Estrogen replacement in perimenopause-related depression: a preliminary report. Am J Obstet Gynecol, 183(2), 414-20. https://doi.org/10.1067/mob.2000.106004

Schmidt, P. J., et al. (2005). Dehydroepiandrosterone monotherapy in midlife-onset major and minor depression. Arch Gen Psychiatry, 62(2), 154-62. https://doi.org/10.1001/archpsyc.62.2.154

Seidman, S. N., & Rabkin, J. G. (1998). Testosterone replacement therapy for hypogonadal men with SSRI-refractory depression. J Affect Disord, 48(2-3), 157-61. https://doi.org/10.1016/s0165-0327(97)00168-7

Seidman, S. N., et al. (2005). Intramuscular testosterone supplementation to selective serotonin reuptake inhibitor in treatment-resistant depressed men: randomized placebo-controlled clinical trial. J Clin Psychopharmacol, 25(6), 584-8. https://doi.org/10.1097/01.jcp.0000185424.23515.e5

Sethi, S., et al. (2024a). Metabolic psychiatry: A conceptual framework targeting metabolic dysfunction in psychiatric disease [Manuscript].

Sethi, S., et al. (2024b). Ketogenic Diet Intervention on Metabolic and Psychiatric Health in Bipolar and Schizophrenia: A Pilot Trial. Psychiatry Res, 335, 115866. https://doi.org/10.1016/j.psychres.2024.115866

Shanmugan, S., & Epperson, C. N. (2014). Estrogen and the prefrontal cortex: towards a new understanding of estrogen's effects on executive functions in the menopause transition. Hum Brain Mapp, 35(3), 847-65. https://doi.org/10.1002/hbm.22218

Shochat, T., et al. (2014). Functional consequences of inadequate sleep in adolescents: a systematic review. Sleep Med Rev, 18(1), 75-87. https://doi.org/10.1016/j.smrv.2013.03.005

Shumaker, S. A., et al. (2004). Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. JAMA, 291(24), 2947-58. https://doi.org/10.1001/jama.291.24.2947

Sibley, M. H., et al. (2018). Late-Onset ADHD Reconsidered With Comprehensive Repeated Assessments Between Ages 10 and 25. Am J Psychiatry, 175(2), 140-149. https://doi.org/10.1176/appi.ajp.2017.17030298

Soares, C. N., et al. (2001). Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial. Arch Gen Psychiatry, 58(6), 529-34. https://doi.org/10.1001/archpsyc.58.6.529

Spiegel, K., et al. (1999). Impact of sleep debt on metabolic and endocrine function. Lancet, 354(9188), 1435-9. https://doi.org/10.1016/S0140-6736(99)01376-8

Spiegel, K., et al. (2004). Brief communication: Sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Ann Intern Med, 141(11), 846-50. https://doi.org/10.7326/0003-4819-141-11-200412070-00008

Stahl, S. M. (2013). Stahl's essential psychopharmacology: Neuroscientific basis and practical applications (4th ed.). Cambridge University Press.

Stahl, S. M. (2021). Stahl's essential psychopharmacology: Neuroscientific basis and practical applications (5th ed.). Cambridge University Press.

Stahl, S. M. (2024). Prescriber's guide: Stahl's essential psychopharmacology (8th ed.). Cambridge University Press. https://doi.org/10.1017/9781009464772

Stanger, O., et al. (2009). Homocysteine, folate and vitamin B12 in neuropsychiatric diseases: review and treatment recommendations. Expert Rev Neurother, 9(9), 1393-412. https://doi.org/10.1586/ern.09.75

Swanson, J., et al. (1999). Acute tolerance to methylphenidate in the treatment of attention deficit hyperactivity disorder in children. Clin Pharmacol Ther, 66(3), 295-305. https://doi.org/10.1016/S0009-9236(99)70038-X

Swanson, J. M., et al. (2017). Young adult outcomes in the follow-up of the multimodal treatment study of attention-deficit/hyperactivity disorder: symptom persistence, source discrepancy, and height suppression. J Child Psychol Psychiatry, 58(6), 663-678. https://doi.org/10.1111/jcpp.12684

Syed, E. U., et al. (2013). Vitamin B12 supplementation in treating major depressive disorder: a randomized controlled trial. Open Neurol J, 7, 44-8. https://doi.org/10.2174/1874205X01307010044

Tan, S., et al. (2019). Effects of Testosterone Supplementation on Separate Cognitive Domains in Cognitively Healthy Older Men: A Meta-analysis of Current Randomized Clinical Trials. Am J Geriatr Psychiatry, 27(11), 1232-1246. https://doi.org/10.1016/j.jagp.2019.05.008

Tanrikut, C., et al. (2010). Adverse effect of paroxetine on sperm. Fertil Steril, 94(3), 1021-6. https://doi.org/10.1016/j.fertnstert.2009.04.039

Thong, F. S., & Graham, T. E. (2002). Caffeine-induced impairment of glucose tolerance is abolished by beta-adrenergic receptor blockade in humans. J Appl Physiol (1985), 92(6), 2347-52. https://doi.org/10.1152/japplphysiol.01229.2001

Tiihonen, J., et al. (2009). 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). Lancet, 374(9690), 620-7. https://doi.org/10.1016/S0140-6736(09)60742-X

van der Kolk, B. A. (2014). The body keeps the score: Brain, mind, and body in the healing of trauma. Viking.

van der Kolk, B. A., et al. (2007). A randomized clinical trial of eye movement desensitization and reprocessing (EMDR), fluoxetine, and pill placebo in the treatment of posttraumatic stress disorder: treatment effects and long-term maintenance. J Clin Psychiatry, 68(1), 37-46.

Vanselow, W., et al. (1996). Effect of progesterone and its 5 alpha and 5 beta metabolites on symptoms of premenstrual syndrome according to route of administration. J Psychosom Obstet Gynaecol, 17(1), 29-38. https://doi.org/10.3109/01674829609025661

Wallace, D. C. (2017). A Mitochondrial Etiology of Neuropsychiatric Disorders. JAMA Psychiatry, 74(9), 863-864. https://doi.org/10.1001/jamapsychiatry.2017.0397

Walther, A., et al. (2019). Association of Testosterone Treatment With Alleviation of Depressive Symptoms in Men: A Systematic Review and Meta-analysis. JAMA Psychiatry, 76(1), 31-40. https://doi.org/10.1001/jamapsychiatry.2018.2734

Wang, G. J., et al. (2013). Long-term stimulant treatment affects brain dopamine transporter level in patients with attention deficit hyperactive disorder. PLoS One, 8(5), e63023. https://doi.org/10.1371/journal.pone.0063023

Watson, K. T., et al. (2021). Incident Major Depressive Disorder Predicted by Three Measures of Insulin Resistance: A Dutch Cohort Study. Am J Psychiatry, 178(10), 914-920. https://doi.org/10.1176/appi.ajp.2021.20101479

Weich, S., et al. (2014). Effect of anxiolytic and hypnotic drug prescriptions on mortality hazards: retrospective cohort study. BMJ, 348, g1996. https://doi.org/10.1136/bmj.g1996

Xie, Y., et al. (2025). Mapping the effectiveness and risks of GLP-1 receptor agonists. Nat Med, 31(3), 951-962. https://doi.org/10.1038/s41591-024-03412-w

Yang, M., et al. (2025). Independent and medication related effects of bipolar disorder on thyroid and reproductive hormones in women. Sci Rep, 15(1), 26962. https://doi.org/10.1038/s41598-025-11460-6

Yanofski, J. (2011). The Dopamine Dilemma-Part II: Could Stimulants Cause Tolerance, Dependence, and Paradoxical Decompensation?. Innov Clin Neurosci, 8(1), 47-53.

Zitzmann, M., et al. (2006). Association of specific symptoms and metabolic risks with serum testosterone in older men. J Clin Endocrinol Metab, 91(11), 4335-43. https://doi.org/10.1210/jc.2006-0401

Next
Next

Do Hormones Cause Cancer? What the Trials That Actually Gave Them Found